These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16628253)

  • 1. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
    Bresson D; Togher L; Rodrigo E; Chen Y; Bluestone JA; Herold KC; von Herrath M
    J Clin Invest; 2006 May; 116(5):1371-81. PubMed ID: 16628253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Delivery of Proinsulin and IL-10 via
    Cook DP; Cunha JPMCM; Martens PJ; Sassi G; Mancarella F; Ventriglia G; Sebastiani G; Vanherwegen AS; Atkinson MA; Van Huynegem K; Steidler L; Caluwaerts S; Rottiers P; Teyton L; Dotta F; Gysemans C; Mathieu C
    Front Immunol; 2020; 11():1103. PubMed ID: 32582188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice.
    Takiishi T; Korf H; Van Belle TL; Robert S; Grieco FA; Caluwaerts S; Galleri L; Spagnuolo I; Steidler L; Van Huynegem K; Demetter P; Wasserfall C; Atkinson MA; Dotta F; Rottiers P; Gysemans C; Mathieu C
    J Clin Invest; 2012 May; 122(5):1717-25. PubMed ID: 22484814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of New Onset Type 1 Diabetes by Oral
    Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
    Front Immunol; 2019; 10():320. PubMed ID: 30863412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells.
    Takiishi T; Cook DP; Korf H; Sebastiani G; Mancarella F; Cunha JP; Wasserfall C; Casares N; Lasarte JJ; Steidler L; Rottiers P; Dotta F; Gysemans C; Mathieu C
    Diabetes; 2017 Feb; 66(2):448-459. PubMed ID: 28108611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy with GABA and proinsulin/alum acts synergistically to restore long-term normoglycemia by modulating T-cell autoimmunity and promoting β-cell replication in newly diabetic NOD mice.
    Tian J; Dang H; Nguyen AV; Chen Z; Kaufman DL
    Diabetes; 2014 Sep; 63(9):3128-34. PubMed ID: 25146474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.
    Kuhn C; Rezende RM; da Cunha AP; Valette F; Quintana FJ; Chatenoud L; Weiner HL
    J Autoimmun; 2017 Jan; 76():115-122. PubMed ID: 27745778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
    Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
    Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation Followed by Antigen-Specific T
    Cabello-Kindelan C; Mackey S; Sands A; Rodriguez J; Vazquez C; Pugliese A; Bayer AL
    Diabetes; 2020 Feb; 69(2):215-227. PubMed ID: 31712320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
    Gliwiński M; Iwaszkiewicz-Grześ D; Wołoszyn-Durkiewicz A; Tarnowska M; Żalińska M; Hennig M; Zielińska H; Dukat-Mazurek A; Zielkowska-Dębska J; Zieliński M; Jaźwińska-Curyłło A; Owczuk R; Jarosz-Chobot P; Bossowski A; Szadkowska A; Młynarski W; Marek-Trzonkowska N; Moszkowska G; Siebert J; Myśliwiec M; Trzonkowski P
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32098895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes.
    Bresson D; Fradkin M; Manenkova Y; Rottembourg D; von Herrath M
    Mol Ther; 2010 Feb; 18(2):307-16. PubMed ID: 19690518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin.
    Zhang W; Jin H; Hu Y; Yu Y; Li X; Ding Z; Kang Y; Wang B
    Hum Gene Ther; 2010 Feb; 21(2):171-8. PubMed ID: 19788384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance.
    von Herrath MG; Coon B; Wolfe T; Chatenoud L
    J Immunol; 2002 Jan; 168(2):933-41. PubMed ID: 11777992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
    Wu HY; Quintana FJ; Weiner HL
    J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes.
    Every AL; Kramer DR; Mannering SI; Lew AM; Harrison LC
    J Immunol; 2006 Apr; 176(8):4608-15. PubMed ID: 16585551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the specificity of regulatory T cells in murine autoimmune diabetes.
    Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q
    Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
    Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
    Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes.
    Jhala G; Chee J; Trivedi PM; Selck C; Gurzov EN; Graham KL; Thomas HE; Kay TW; Krishnamurthy B
    JCI Insight; 2016 Jul; 1(10):e86065. PubMed ID: 27699217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.
    Mathieu C; Wiedeman A; Cerosaletti K; Long SA; Serti E; Cooney L; Vermeiren J; Caluwaerts S; Van Huynegem K; Steidler L; Blomme S; Rottiers P; Nepom GT; Herold KC;
    Diabetologia; 2024 Jan; 67(1):27-41. PubMed ID: 37782353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.